Tazemetostat Plus CHOP in 1L T-cell Lymphoma

EZH2 inhibitor, 200 mg tablet, taken orally per protocol.

Anthracycline antibiotic, 10, 20, 50, 100, and 200 mg vials, via intravenous (into the vein) infusion per institutional standard of care.

Vinca Alkaloid, 1, 2, and 5mL vials, via intravenous (into the vein) infusion per institutional standard of care.

Corticosteroid, 1, 2.5, 5, 10, 20, 25, and 50 mg tablets, taken orally per institutional standard of care.

Alkylating agent, 100mg, 200 mg, and 500mg vials, and 1 and 2 gram vials, via intravenous (into the vein) infusion per institutional standard of care.

Alkylating agent, 100 mg single dose vials, via intravenous (into the vein) infusion per institutional standard of care.

Topoisomerase II inhibitor, 100mg single dose vial, via intravenous (into the vein) infusion per institutional standard of care.

Antineoplastic, 20mg single dose vial, via intravenous, intrathecal, or subcutaneous injection per institutional standard of care

Alkylating agent, 90 mg multi-dose vial, via parenteral infusion per institutional standard of care.